125 related articles for article (PubMed ID: 36116374)
1. N-glycosylation of CD82 at Asn157 is required for suppressing migration and invasion by reversing EMT via Wnt/β-catenin pathway in colon cancer.
Zhu L; Chen Y; Du H; Cong Y; Yan W; Ma K; Huang X
Biochem Biophys Res Commun; 2022 Nov; 629():121-127. PubMed ID: 36116374
[TBL] [Abstract][Full Text] [Related]
2. The peptide mimicking small extracellular ring domain of CD82 inhibits epithelial-mesenchymal transition by downregulating Wnt pathway and upregulating hippo pathway.
He X; Huang X; Wang C; Luan M; Li Y; Ma X; Ma K
Biochem Biophys Res Commun; 2020 Dec; 533(3):338-345. PubMed ID: 32958256
[TBL] [Abstract][Full Text] [Related]
3. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
4. ADAMDEC1 induces EMT and promotes colorectal cancer cells metastasis by enhancing Wnt/β-catenin signaling via negative modulation of GSK-3β.
Jia Y; Huang X; Shi H; Wang M; Chen J; Zhang H; Hou D; Jing H; Du J; Han H; Zhang J
Exp Cell Res; 2023 Aug; 429(2):113629. PubMed ID: 37187249
[TBL] [Abstract][Full Text] [Related]
5. MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
Li J; Xu J; Li L; Ianni A; Kumari P; Liu S; Sun P; Braun T; Tan X; Xiang R; Yue S
Theranostics; 2020; 10(14):6467-6482. PubMed ID: 32483464
[No Abstract] [Full Text] [Related]
6. CD82 inhibits canonical Wnt signalling by controlling the cellular distribution of β-catenin in carcinoma cells.
Chigita S; Sugiura T; Abe M; Kobayashi Y; Shimoda M; Onoda M; Shirasuna K
Int J Oncol; 2012 Dec; 41(6):2021-8. PubMed ID: 23076981
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin CD82 represses Sp1-mediated Snail expression and the resultant E-cadherin expression interrupts nuclear signaling of β-catenin by increasing its membrane localization.
Lee MS; Byun HJ; Lee J; Jeoung DI; Kim YM; Lee H
Cell Signal; 2018 Dec; 52():83-94. PubMed ID: 30189244
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol inhibits invasion and metastasis in colorectal cancer cells by reversing epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Feng P; Zhu L; Jie J; Yang P; Sheng N; Chen X; Chen X
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3587-3598. PubMed ID: 35960375
[TBL] [Abstract][Full Text] [Related]
9. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
10. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract][Full Text] [Related]
11. A novel function of CD82/KAI-1 on E-cadherin-mediated homophilic cellular adhesion of cancer cells.
Abe M; Sugiura T; Takahashi M; Ishii K; Shimoda M; Shirasuna K
Cancer Lett; 2008 Aug; 266(2):163-70. PubMed ID: 18395972
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.
Chai WX; Sun LG; Dai FH; Shao HS; Zheng NG; Cai HY
Pathol Res Pract; 2019 Oct; 215(10):152593. PubMed ID: 31471104
[TBL] [Abstract][Full Text] [Related]
13. Parecoxib expresses anti-metastasis effect through inhibition of epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway in human colon cancer DLD-1 cell line.
Wong CH; Chang WL; Lu FJ; Liu YW; Peng JY; Chen CH
Environ Toxicol; 2022 Nov; 37(11):2718-2727. PubMed ID: 35917206
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-338 inhibits proliferation, migration, and invasion of gastric cancer cells by the Wnt/β-catenin signaling pathway.
Song B; Lin HX; Dong LL; Ma JJ; Jiang ZG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1290-1296. PubMed ID: 29565486
[TBL] [Abstract][Full Text] [Related]
15. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
[TBL] [Abstract][Full Text] [Related]
16. ARHGAP25: A negative regulator of colorectal cancer (CRC) metastasis via the Wnt/β-catenin pathway.
Tao L; Zhu Y; Gu Y; Zheng J; Yang J
Eur J Pharmacol; 2019 Sep; 858():172476. PubMed ID: 31228451
[TBL] [Abstract][Full Text] [Related]
17. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling.
Chairoungdua A; Smith DL; Pochard P; Hull M; Caplan MJ
J Cell Biol; 2010 Sep; 190(6):1079-91. PubMed ID: 20837771
[TBL] [Abstract][Full Text] [Related]
18. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
Gao S; Hu J; Wu X; Liang Z
Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
[TBL] [Abstract][Full Text] [Related]
19. PCDH8 participates in the growth process of colorectal cancer cells by regulating the AKT/GSK3β/β-catenin signaling pathway.
Wu S; Li X; Yang J; Yang L
Tissue Cell; 2022 Oct; 78():101864. PubMed ID: 35907345
[TBL] [Abstract][Full Text] [Related]
20. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
Yan D; Avtanski D; Saxena NK; Sharma D
J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
